4.7 Review

MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer

Journal

BIOMEDICINES
Volume 9, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines9040347

Keywords

microRNAs; hepatocellular carcinoma; Hippo kinase; Yes-associated protein; liver disease; diagnosis; prognosis; cancer therapy

Funding

  1. National Research Foundation of Korea [2020R1F1A1073695, 2021R1C1C1003904]
  2. National Research Foundation of Korea [2020R1F1A1073695, 2021R1C1C1003904] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Liver cancer is one of the most common cancers worldwide, with increasing prevalence and mortality due to the lack of biomarkers and effective treatments. The Hippo-YAP/TAZ signaling pathway and miRNAs play critical roles in the pathogenesis of liver cancer, and understanding these mechanisms may provide insights for overcoming liver cancer.
Liver cancer is one of the most common cancers worldwide, and its prevalence and mortality rate are increasing due to the lack of biomarkers and effective treatments. The Hippo signaling pathway has long been known to control liver size, and genetic depletion of Hippo kinases leads to liver cancer in mice through activation of the downstream effectors yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). Both YAP and TAZ not only reprogram tumor cells but also alter the tumor microenvironment to exert carcinogenic effects. Therefore, understanding the mechanisms of YAP/TAZ-mediated liver tumorigenesis will help overcome liver cancer. For decades, small noncoding RNAs, microRNAs (miRNAs), have been reported to play critical roles in the pathogenesis of many cancers, including liver cancer. However, the interactions between miRNAs and Hippo-YAP/TAZ signaling in the liver are still largely unknown. Here, we review miRNAs that influence the proliferation, migration and apoptosis of tumor cells by modulating Hippo-YAP/TAZ signaling during hepatic tumorigenesis. Previous findings suggest that these miRNAs are potential biomarkers and therapeutic targets for the diagnosis, prognosis, and treatment of liver cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available